Sally Walsh
Impact in
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
-
- Medicinal Plants and Neuroprotection
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 2
- Pharmacological Effects of Medicinal Plants 1
-
- Computational Drug Discovery Methods 2
- Co-authors
- Paul Aisen (2 shared papers)John T. Little (2 shared papers)Rema Raman (1 shared paper)Ronald G. Thomas (1 shared paper)Michael S. Rafii (1 shared paper)Carwyn Ward (1 shared paper)Brigid Reynolds (1 shared paper)K A Behan (1 shared paper)
- Journals
- Alzheimer Disease & Associated Disorders (1 paper)Expert Opinion on Investigational Drugs (1 paper)Neurology (1 paper)Expert Review of Neurotherapeutics (1 paper)Expert Review of Medical Devices (1 paper)
- Partner nations
- United StatesIreland
In The Last Decade
Sally Walsh
5 papers receiving 323 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 141
- Complementary and alternative medicine 63
- Psychiatry and Mental health 81
- Physiology 109
- Neurology 33
Countries citing papers authored by Sally Walsh
This map shows the geographic impact of Sally Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Walsh more than expected).
Fields of papers citing papers by Sally Walsh
This network shows the impact of papers produced by Sally Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Walsh. The network helps show where Sally Walsh may publish in the future.
Co-authors
The 11 scholars most cited alongside Sally Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 175 | |
| 2 | 2006 | 78 | |
| 3 | 2008 | 49 | |
| 4 | 2004 | 19 | |
| 5 | 2004 | 12 |
About Sally Walsh
Sally Walsh is a scholar working on Pharmacology, Computational Theory and Mathematics, Physiology, Neurology and Cardiology and Cardiovascular Medicine, having authored 5 papers that have together received 333 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (2 papers), Alzheimer's disease research and treatments (2 papers), Computational Drug Discovery Methods (2 papers), Pharmacological Effects of Medicinal Plants (1 paper), EEG and Brain-Computer Interfaces (1 paper), Nutritional Studies and Diet (1 paper), Neurological disorders and treatments (1 paper) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Pharmacology (141 citations), Complementary and alternative medicine (63 citations), Psychiatry and Mental health (81 citations), Physiology (109 citations) and Neurology (33 citations). Sally Walsh has collaborated with scholars based in United States and Ireland. Frequent co-authors include Paul Aisen, John T. Little, Paul Aisen, Rema Raman, Ronald G. Thomas, Michael S. Rafii, Carwyn Ward, Brigid Reynolds, K A Behan and Shelia Jin. Their work appears in journals such as Alzheimer Disease & Associated Disorders, Expert Opinion on Investigational Drugs, Neurology, Expert Review of Neurotherapeutics and Expert Review of Medical Devices.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.